Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy
NCT ID: NCT07276646
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2025-12-10
2026-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Effectivity of Erector Spina Plane Block With Different Levels
NCT04316416
External Oblique Intercostal Block in Laparoscopic Cholecystectomy
NCT07164664
Erector Spinae Plane Block Versus Thoracic Paravertebral Block in Laparoscopic Cholecystectomy
NCT07149584
Comparation of Bilateral and Unilateral Erector Spinae Plane Block
NCT05152602
Ultrasound Guided : Retrolaminar Block Versus Thoracic Epidural Analgesia Following Laparoscopic Cholecystectomy
NCT04835415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To compare the analgesic outcomes (time to first analgesic request, total amount of analgesic consumption and pain scores by NRS)
* To assess the block performance time required to perform each technique .
* To compare intraoperative parameters (hemodynamics and intraoperative fentanyl consumption)
* To assess patient, surgeon satisfaction and complications of the block.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrosuperior costotransverse ligament block group
The patient will receive retrosuperior costotransverse ligament block
Retrosuperior costotransverse ligament block group
The patient will receive retrosuperior costotransverse ligament block
Erector spinae block group
The patient will receive erector spinae block.
Erector spinae block group
The patient will receive erector spinae block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retrosuperior costotransverse ligament block group
The patient will receive retrosuperior costotransverse ligament block
Erector spinae block group
The patient will receive erector spinae block.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age: 21-64 years old.
3. Sex: both sexes.
4. Physical status: ASA I \& II.
5. Body mass index (BMI): 18.5 - 30 kg/m2.
6. Type of operations: elective laparoscopic cholecystectomy.
7. Duration of surgery not more than 2 hours.
Exclusion Criteria
2. Patients with respiratory insufficiency.
3. Coagulation disorders or taking drugs affect surgical hemostasis.
7\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases
21 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Abdelhameed Elsadek Salem
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of human medicine, Zagazig university, Zagazig
Zagazig, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Dina Salem, MD
Role: CONTACT
Marwa Medhat, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1783
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.